PACB: Koefisien rega marang pendapatan Pacific Biosciences of California
Pacific Biosciences dominates high-accuracy HiFi sequencing, implementing AI algorithms and innovative Revio and Onso systems to expand its presence in the genomics market. Fluctuations in the P/S multiple reflect the business valuation dynamics, with the indicator reaching 3.80. The company's stability is supported by the diversification of solutions for microbiology, the agricultural sector, and clinical genetics, which significantly reduces operational risks.
Rincian analitis perusahaan Pacific Biosciences of California (PACB)
- rega saiki lan proyeksi nilai saham:
- informasi kapitalisasi pasar:
- rincian nilai buku perusahaan:
- indikator beban kredit lan likuiditas emiten:
Rasio Total Utang marang Ekuitas Pacific Biosciences|PACB - Utang jangka dawa marang modal|Koefisien utang jangka cendhak marang modal PacBio Corp|PACB - Gunggung utang perusahaan|Utang-utang marang nilai buku Pacific Biosciences of California|PACB - Utang jangka dawa perusahaan|Tanggungan utang jangka cendhak perusahaan PacBio|Indikator likuiditas cepet pacb.com
- data bathi lan kelipatan valuasi:
PACB - Bathi resik|Bathi resik sing dikarepake Pacific Biosciences|PACB - Rasio rega marang bathi|Kapitalisasi marang proyeksi bathi Pacific Biosciences of California, Inc.|PACB - Rasio rega marang bathi tumrap wutah|Rasio nilai perusahaan marang bathi operasional sadurunge panyusutan Pacific Biosciences of California|PACB - Bathi operasional EBITDA|Bathi resik saben saham (EPS TTM) PacBio|PACB - Bathi resik saben saham (EPS TTM)|Wutah bathi resik saben saham taun-ka-taun sajrone 12 wulan pungkasan pacb.com|PACB - Wutah bathi ing taun lumaku|Prakiraan wutah bathi resik saben saham kanggo taun ngarep Pacific Biosciences
- data total pendapatan lan volume dodolan:
Analisis umum perusahaan:PACB - pacb.com
The P/S ratio reflects the market value of the business per unit of generated revenue, allowing for an assessment of the premium paid for future revenue growth. Analyzing the current price-to-sales value is critical for Pacific Biosciences (PACB), as US export restrictions and chip supply disruptions directly impact the deployment rates of sequencing systems, determining the fundamental fairness of the company's market valuation.
Pesaing Pacific Biosciences
Rasio rega marang pendapatan TEM (Tempus AI)|Multiplikator P/S QGEN (Qiagen)|Koefisien rega marang pendapatan Ionis Pharmaceuticals, Inc. (IONS)|RGEN - Rasio rega marang pendapatan|Rega marang dodolan Avidity Corp|CRISPR Therapeutics AG (CRSP) - Rasio rega marang pendapatan|WGS - Koefisien rega marang pendapatan|RARE (Ultragenyx) - Multiplikator P/S|Kapitalisasi marang pendapatan Beam Therapeutics Inc (BEAM)|Multiplikator P/S SRPT|Koefisien rega marang pendapatan Twist Bioscience Corp|Multiplikator P/S TXG (10x Genomics, Inc.)|intelliatx.com (NTLA) - Rega marang dodolan|STOK - Rasio rega marang pendapatan|BLFS (BioLife Solutions Inc) - Rasio kapitalisasi marang pendapatan|WVE: Multiplikator P/S|Kapitalisasi marang pendapatan Maze Therapeutics Corp|SION (Sionna Therapeutics Inc) - Multiplikator P/S|Rega marang dodolan primemedicine.com PRME|Rasio rega marang pendapatan Taysha Gene Therapies, Inc. (TSHA)|Koefisien rega marang pendapatan uniQure NV|Rasio rega marang pendapatan MeiraGTx PLC MGTX|RGNX (REGENXBIO Corp) - Rasio rega marang dodolan|Solid Biosciences Inc. - Multiplikator P/S|OCGN - Multiplikator P/S|BNTC: Multiplikator P/S|Kapitalisasi marang pendapatan Design Therapeutics Inc|RCKT (Rocket Pharmaceuticals Inc) - Multiplikator P/S|Rasio rega marang pendapatan FDMT|Multiplikator P/S LXEO|korrobio.com - Rasio kapitalisasi marang pendapatan|Rasio rega marang pendapatan Editas Medicine EDIT|SLN: Rasio kapitalisasi marang pendapatan|ProQR Therapeutics NV - Multiplikator P/S|CDXS - Multiplikator P/S|Sangamo Therapeutics (SGMO) - Rasio rega marang pendapatan|Rasio rega marang dodolan NAUT (Nautilus Bio)|MGX (Metagenomi) - Multiplikator P/S|Multiplikator P/S precisionbiosciences.com|Multiplikator P/S GBIO|Kapitalisasi marang pendapatan Boundless Bio Inc BOLD|Multiplikator P/S XCUR (Exicure)|Koefisien rega marang pendapatan Imunon Inc (IMNN)|RXi Pharmaceuticals - Multiplikator P/S|Rasio rega marang dodolan MBIO|RNAZ: Multiplikator P/S|BNGO - Koefisien rega marang pendapatan|APDN (Applied DNA Sciences) - Multiplikator P/S|Kapitalisasi marang pendapatan bluebirdbio.com (BLUE)|Kapitalisasi marang pendapatan IPA (ImmunoPrecise Antibodies)|OMGA (Omega Therapeutics Inc) - Rasio kapitalisasi pasar marang pendapatan|Multiplikator P/S OMIC (Singular Genomics Systems Inc)|Regulus - Rasio rega marang pendapatan|Syros Pharmaceuticals - Multiplikator P/S|Koefisien rega marang pendapatan telesisbio.com TBIO|TRACON Pharmaceuticals, Inc. (TCON) - Rasio rega marang pendapatan|Rega marang dodolan Unity Biotechnology Inc. (UBX)
